Analyzing the Applicability of Wound Care Biologics and the Innovations Launched in the Market

The healthcare sector has undergone a lot of changes from the technological and medical point of view. Advanced technologies have been introduced in the industry and better drugs have been formulated. Biologics is one such segment that has progressed significantly in the recent past. The term biologics refers to such drugs which have been made or sourced from living organisms. Wound care biologics, thus, indicates the use of biologic drugs for the treatment of wounds.?

Applications of Wound Care Biologics?

Wound care biologics are mainly used in procedures like stem cell therapies and skin substitution. In stem cell therapies, stem cells due to their high regenerative capacity, are transplanted to the wound site for quicker healing. In skin substitution procedures, wound care biologic drugs are used to cover the wound from externalities like dust, moisture, pathogens, etc. In certain cases, biologics are also used as growth factors and bioartificial scaffolds.??

The most common applications of wound care drugs include hydrogels and film dressings. Hydrogel, as the name suggests, are polymer network structure with the ability to imbibe large amounts of water. Thus, hydrogels are mainly used in such wounds where maintaining moisture around the wound is important. Film dressings, on the other hand, have certain growth factors and biologics attached to the polymer network which aid in quicker healing of the wound.??

Influential factors affecting the growth of the market?

A recently published report by Allied Market Research states that the global wound care biologics market is predicted to surge at a CAGR of 6.1% in the 2023-2032 timeframe. As per the report, the growing global geriatric population has a huge role to play in this expected growth. Since the geriatric population is generally more susceptible to wounds and injuries, a growth in their population will naturally increase the demand for wound care drugs. Another important factor underlined by the report is the growing prevalence of diabetic foot ulcers and accidental wounds which have led to a surge in demand for wound care biologic drugs.??

A general increase in the pace of advancements in wound care management is also responsible for the huge growth the market has witnessed. The use of nanofibers for wound care dressings or extracellular matrix-derived biologics are some examples of advancements in wound care management. Such innovative techniques are predicted to help the market to grow in the analysis period.?

?Innovative product launches by major players in the industry?

The wound care biologics industry is a competitive one with many major companies engaged in a healthy tussle to establish their dominance in the market. To take a lead over their competitors, these companies have invested heavily in R&D activities to develop innovative products and launch them in the market. For example, MTF Biologics, a leading non-profit organization specializing in tissue and organ donation, in April 2023 launched a product called AlloPatch Pliable Meshed. Designed for treating diabetic foot and venous leg ulcers, AlloPatch Pliable Meshed is a reticular dermal allograft that can be used in both acute and post-acute settings.?

To conclude, increasing integration with advanced sciences will surely help the market to grow in the next few years. Moreover, the demographic changes in the global population might also push the growth rate of the market higher. Along with this, R&D activities and innovations will play a huge role in expanding the scope of the industry in the coming period.?

? **?????????????? ????????????: Akhilesh Prabhugaonkar ?

?